As the results showed, female GC patients with high PRDX2 mRNA expression exhibited a 48% reduction in risk of death, which suggested prognostic evaluation using PRDX2 mRNA expression had additional value in female patients compared with male patients. The gene discussed is PRDX2; the disease is gastric cancer.